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Abstract 
Aim: Patient reported outcome measures (PROMs) are standard in the assessment of 
colorectal cancer (CRC) treatment, but the range and complexity of available PROMs may 
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be hindering evidence synthesis. This systematic review aimed to 1) summarise PROMs in 
studies of CRC surgery and 2) categorise PRO content to inform the future development of 
an agreed minimum ‘core’ outcome set to be measured in all trials. 
Method: All PROMs were identified from a systematic review of prospective CRC surgical 
studies. The type and frequency of PROMs in each study were summarized, and numbers of 
items documented. All items were extracted and independently categorized by content by 
two researchers into ‘health domains’ and discrepancies discussed with a patient and expert. 
Domain popularity and distribution of items were summarized.  
Results: 58 different PROMs were identified from the 104 included studies. There were 23 
generic, 4 cancer specific, 11 disease and 16 symptom specific questionnaires, and 3 ad 
hoc measures. The most frequently used PROM was the EORTC QLQ-C30 (50 studies), 
and most PROMs (40,69%) were used in only one study. Detailed examination of the 50 
available measures identified 917 items, which were categorized into 51 domains. The 
domains comprising the most items were ‘anxiety’ (n=85,9.2%), ‘fatigue’ (n=67,7.3%), and 
‘physical function’ (n=63,6.9%). No domains were included in all PROMs 
Conclusion: There is major heterogeneity of PRO measurement and wide variation in 
content assessed by PROMs available for CRC. A core outcome set will improve PRO 
outcome measurement and reporting in CRC trials. 
 
What does this paper adds to the literature? 
 The review summarises colorectal cancer surgical PROMs and demonstrates major 
heterogeneity in PRO measurement in trials that hinders evidence synthesis and meta-
analysis. PROMs were categorized to inform the development of a core outcome set to 
resolve this problem. 
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Introduction 
The measurement of patient reported outcomes (PROs) has become standard in the 
assessment of colorectal cancer treatments, and their use is recommended by funding and 
regulatory agencies1. Many patient-reported outcome measures (PROMs) have therefore 
been developed for a variety of purposes2. Some are generic, and allow comparisons 
between patients with other conditions (e.g. SF-36, EQ-5D). Others are designed for patients 
with cancer (e.g. EORTC QLQ-C30, FACT-G), and some are specific for colorectal cancer 
(e.g. EORTC-CR29, FACT-C). To add further complexity, each of these PROMs typically 
consist of a number of questions (items), which are often grouped together to represent 
similar concepts (scales). For example, two questions regarding activities of daily living and 
leisure activities in the EORTC QLQ-C30 measure are grouped into a single “role function” 
scale. There are therefore a multitude of ways to measure PROs to evaluate treatment for 
colorectal cancer, and this creates problems that may influence the conduct and clinical 
impact of trials. 
 
Trials may use different PROMs3,4 making it impossible to synthesize data across trials or 
undertake meta-analyses. The multiplicity of results available from trials means that it is 
difficult to interpret findings in the context of clinical practice because of lack of familiarity 
with the number of measures, scales and items2. For example, the scale “physical function” 
exists in several different PROMs, but individual items in these scales vary considerably 
between questionnaires. This is confusing for clinicians, who may not be aware of the 
differences between PROMs and it is likely to limit the meaningful use of the data in practice.  
Finally, the opportunities of multiple outcome measurement may lead to selective reporting 
of significant findings. This can generate bias and influence clinical interpretation of trials5. 
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A proposed solution to these issues are “core outcome sets”. Core outcomes are the 
minimum set of outcomes that patients and professionals agree to be measured in all trials 
of a certain condition6. They aim to facilitate comparisons between trials and aid meta-
analysis by standardising outcome measurement, including PROs. The use of core sets may 
also facilitate clinical communication of data. Many core outcome sets have now been 
developed in different clinical areas including rheumatology7, paediatrics8 and obstetrics9, 
but not in colorectal cancer surgery. This systematic review aims to examine the 
measurement of PROs in colorectal cancer (CRC) surgical studies, and use the data to 
inform the development of the core outcome set. 
 
Method 
A systematic review of prospective colorectal cancer surgical studies measuring PROs was 
undertaken to 1) summarise PRO measurement in CRC surgical studies, and 2) examine 
each PROM in detail, and categorize analogous concepts into domains to inform the future 
development of a core outcome set. 
 
Systematic search and data extraction 
This systematic review adhered to a pre-defined protocol (available on request from 
authors).  Validated terms relating to ‘surgery’, ‘colorectal cancer’ and ‘prospective studies’ 
(Table 4) were used to search the OVID SP versions of MEDLINE, EMBASE and the 
Cochrane Central Register of Controlled Trials. A validated filter for ‘prospective studies’ was 
used because PRO data are typically collected prospectively. The search was limited to 
studies conducted in humans aged 18 years and over, reported in the English language 
between January 2009 and December 2010. Previous reviews have considered PROs of 
colorectal cancer surgery in terms of elderly patients10, methodological challenges in 
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measuring PROs in colorectal cancer11, laparoscopic surgery12, long-term survivors13, rectal 
cancer3, and colorectal cancer before 200914. The studies identified in these reviews were 
included. All citations were collated with Reference Manager 12 (Thomson Reuters, New 
York, USA) and the duplicates removed.   
 
Titles and abstracts of identified publications were screened by one researcher.  If there was 
uncertainty about the eligibility of a publication, the full paper was also accessed.  Articles 
were included if they were original research papers reporting PROs of CRC surgery (curative 
or palliative), with or without neoadjuvant or adjuvant therapies, or systematic reviews of 
such publications. PROs were defined as endpoints provided by patients themselves and not 
interpreted by observers. Excluded were studies of non-biomedical interventions (e.g. 
alternative medicine), palliative treatments that did not include a surgical component (e.g. 
palliative chemotherapy), screening studies, treatment of colorectal metastases and 
molecular and genetic prognostic studies.  Studies of more than one cancer site or of mixed 
benign and malignant disease were included provided the data for CRC patients was 
presented separately to that of the other diseases.   
 
Data extraction included participant demographics (number, age and gender); treatment 
received (surgery, neoadjuvant radiotherapy/chemoradiation and adjuvant chemotherapy); 
treatment intent (curative or palliative); the study design (randomized trial, case-control 
study, cohort study, cross-sectional study, prospective case series or other design); the PRO 
questionnaire used; and the individual items included in each questionnaire.  When the 
individual questionnaires were not available in publications, internet searches and direct 
contact with authors were used to obtain the information. All data were entered into a 
Microsoft Access (Microsoft, Washington, USA) database to facilitate data management and 
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analyses.  The data extraction was checked by a second reviewer (ROF) for a sample of 
included articles (n=25) and any disagreements were discussed and resolved with the senior 
author (JMB). 
 
1) Summary of PRO measurement in CRC surgery 
The number of publications reporting each PROM was tabulated and descriptive statistics 
used to summarise PRO measurement.  Popularity of PROMs was assessed by comparing 
the frequency of use in studies. A summary of each PROM is provided in terms of the 
numbers of items, scales and whether a total score is used. The distribution of items among 
PROMs was examined by calculating the median number and range of items per PROM. 
Questionnaires were categorized as 1) generic (for use in all patients); 2) cancer-specific (for 
use in all cancer patients); 3) CRC-specific (for use in colorectal cancer patients); 4) 
symptom-specific (to assess a single symptom e.g. pain) or 5) ad-hoc.  
 
2) Examination of PROs and domain categorization 
Individual items from all questionnaires were extracted and formed into a long-list before 
categorization into health domains by two researchers (RNW and JR).  Both were kept 
masked as to which PRO questionnaire the items were derived from.  Two patient 
representatives (JEJ and GS) and one consultant colorectal surgeon (AMP) subsequently 
checked this process. Discrepancies were discussed and resolved with the senior author 
(JMB).  
 
Categorization was summarised using descriptive statistics to explore the distribution of 
items and PROMs between domains. Numbers of items included in each domain were 
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counted, as were the number of PROMs from which they were sourced. The contribution of 
each source PROM was demonstrated by calculating the median number and range of items 
included from the measures. 
 
Results 
A total of 5644 titles and abstracts was identified, of which 2127 were duplicates. The 
remaining 3517 were screened and 29 original research articles included.  In addition to this, 
six systematic reviews of PROs in CRC surgery identified a further 72 original research 
articles (Figure 1).  In total, 102 original publications including 25 RCTs (25%) and 77 non-
randomised studies (75%) reporting the outcome for 66,386 patients with CRC15-117 were 
included.  Studies are summarised in Table 1.   
 
1) Summary of PRO measurement in CRC surgery  
Fifty eight different PRO questionnaires were identified and these were reported 184 times in 
the included publications (Table 2).  There were 23 (39.7%) generic questionnaires, 4 (6.9%) 
cancer-specific questionnaires, 11 (19.0%) CRC-specific questionnaires and 17 (29.3%) 
symptom-specific questionnaires. Three ad-hoc questionnaires (those devised specifically 
for the study) were not categorized.  
 
Most questionnaires were reported only once (n=40, 69.0%).  The most frequently reported 
were the European Organisation for the Research and Treatment of Cancer (EORTC) QLQ-
C30 (50 studies, 48%), the EORTC QLQ-CR38 (33 studies, 32%) and the Medical Outcome 
Study Short Form-36 (n=21, 21%). The median number of items per PROM was 14, and 
ranged from one (five PROMs: Visual Analogue Scale (overall, pain and wound satisfaction), 
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Satisfaction with Sexual Function, and Present Pain Intensity Index) to 65 (the Profile of 
Mood States). Some 159 scales were evident, and most PROMs (48 [83%]) included a total 
score. 
 
2) Examination of PROs and domain categorization 
Fifty (86.2%) full questionnaires were available. Reasons for unavailability were because of 
inability to obtain the questionnaires from authors or web searches (n=6) or lack of an 
English language translation (n=2).  The 50 questionnaires comprised some 917 individual 
items, and were categorised into 51 domains as described above (Table 3). The full 
categorization is presented in Table 5 (online supplement). The domains comprising the 
most items were ‘anxiety’ (n=85, 9.2%), ‘fatigue’ (n=67, 7.2%), and ‘physical function’ (n=63, 
6.8%).  The disease specific domains comprising most items were ‘faecal incontinence’ 
(n=53, 5.7%) and ‘stoma problems’ (n=52, 5.6%). Most domains (27, 53%) contained 10 or 
more items.  
 
There was little evidence of consistency between PROMs. No domains were measured in all 
the PROMs. The two domains that were best represented were ‘anxiety’ and ‘social 
function’, each measured by 22 (44%) PROMs. Otherwise, most domains (39, 76%) were 
measured by less than a quarter of PROMs, highlighting further heterogeneity. There were 
two domains with a high median number of items included per PROM: ‘Stoma problems’, 
which contained 52 items from only five PROMs (median 7 items per PROM) and 
‘Satisfaction with care’, which featured six items from just one PROM. This may reflect 
specialization of PROMs, with some measures focusing on very specific concepts. 
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Discussion 
This systematic review aimed to summarise PRO measurement in contemporary CRC 
surgical studies and categorise PRO items into analogous concepts to inform the 
development of a core outcome set. There was evidence of significant heterogeneity of PRO 
measurement in the included studies. Fifty eight different PROMs were used to assess 
patient experience of colorectal surgery. Most (40, [69.0%]) were only ever used once, and 
even the most common (EORTC QLQ-C30) was measured in less than half of studies. 
PROMs also varied greatly in terms of their content, with some as simple as a single item, 
and others including up to 65. Most (52%) of PROMs were not designed to be specific to 
CRC surgery or symptoms thereof and, although this may bring benefits in terms of 
comparison between diseases, they may not be sensitive enough to issues that are of 
specific importance to patients with CRC. Over 900 individual questionnaire items were 
evident from 50 PROMs and, through a rigorous process, these were categorized into 51 
‘health domains’. This demonstrated a further lack of consistency, with no domains being 
measured in all the PROMs, and most health domains only being measured by less than a 
quarter of PROMs. All of this highlights potentially major questions for evidence synthesis 
and clinical interpretation of results in studies of CRC surgery, and demonstrates the need 
for a standardized core outcome set.  
 
Other studies have highlighted the problem with outcome heterogeneity for clinical and PRO 
data. A recently published systematic review identified 194 studies of colorectal cancer 
surgery that measured 766 different clinical outcomes, with no single outcome reported in 
all118. Even considering a seemingly simple outcome such as mortality, there were over 84 
different ways that this was defined and measured. The same problem has been highlighted 
in studies of oesophageal cancer surgery119, where a review of 122 articles reported 210 
unique complications and 10 different measures of operative mortality, and breast 
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reconstruction following mastectomy for cancer120, which identified 134 studies reporting 950 
unique complications. The problem with multiplicity of PRO measures has also been 
described previously in oesophageal surgery121, but there is no evidence of this issue in 
trials of CRC surgery.  
 
This study is the largest systematic review of PROs in colorectal cancer and was conducted 
with rigorous methodology, but there are some limitations. The review covers published 
colorectal cancer studies in English up until 2010. A more exhaustive search over a more 
recent period of time, or inclusion of unpublished data or non-English publications may have 
yielded further PROs, but all the most commonly used PROs were captured by these 
inclusion criteria and extending the review is likely to have only identified additional rare 
PROs. The categorization process could be criticized as arbitrary, but efforts were made to 
objectify the process. First, two researchers categorized the questionnaire items 
independently and blinded to the other. Second, categorization was checked for face validity 
by a patient representative. Finally, there has been full disclosure of the categorization in this 
article to allow scientific scrutiny of the process.   
 
Having identified all the potential patient reported health domains measured in CRC surgical 
studies, the next phase of this research is to gain a consensus on which outcomes are 
essential to measure in all trials. Recommended methods to achieve this have been defined 
by the international Core Outcome Measurement in Effectiveness Trials (COMET) group6. 
Domains will be combined with clinical outcomes generated from a previous systematic 
review118 to create an exhaustive long list of all potential outcomes. Key stakeholders, 
including patients and professionals, will then consider the importance of these outcomes 
and undertake a prioritization exercise called a Delphi process. This will allow the outcomes 
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of lower importance to be discarded from the core set. Finally, when the number of 
outcomes has been reduced, face-to-face meeting will be conducted to allow for debate 
about their relative merits, before the final core set is agreed.  
 
In conclusion, this systematic review of CRC surgery demonstrated significant PRO 
measurement heterogeneity that may hinder comparisons between studies, limit meta-
analysis and allow outcome reporting bias. A long-list of patient reported ‘health domains’ 
was generated using robust methodology to inform the development of a core outcome set. 
 
 
Table 1 
Summary of included articles. 
 
  All studies 
n=102 
Randomised trials 
n=25 
Non-randomised studies 
n=77 
Number of participants 66,386 7,172 59,214 
Age range of participants (years) 18 – 99 29 – 89 18 – 99 
Number of participating centres (%):  
   Single 
   Multiple 
 
58 (57) 
44 (43) 
 
13 (52) 
12 (48) 
 
45 (58) 
32 (42) 
IRB or ethical approval reporteda (%) 52 (51) 14 (56) 38 (49) 
Tumour site (%): 
   Colon 
   Rectum 
   Mixed colon and rectum  
 
10 (9) 
54 (53) 
38 (38) 
 
2 (8) 
11 (44) 
12 (48) 
 
7 (9) 
44 (55) 
26 (34) 
Surgical approach (%): 
   Laparoscopy 
   Hand-assisted laparoscopy 
   Open 
   Mixed 
   Not reported or incomplete information reported 
 
1 (1) 
0  
5 (5) 
13 (12) 
83 (81) 
 
0  
0  
1 (4) 
9 (36) 
15 (60) 
 
1 (1) 
0  
4 (5) 
5 (6) 
67 (87) 
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Neoadjuvant treatmentb (%):  
   Radiotherapy alone 
   Chemotherapy alone 
   Chemoradiotherapy 
   None 
   Not reported or incomplete information reported     
 
20 (20) 
0 
22 (22) 
7 (7) 
53 (51) 
 
9 (36) 
0 
3 (12) 
1 (4) 
12 (48) 
 
11 (14) 
0 (0.0) 
18 (24) 
6 (8) 
42 (54) 
Adjuvant treatmentb (%):  
   Chemotherapy or chemoradiotherapy 
   None 
   Not reported or incomplete information reported 
 
56 (55) 
0 
46 (45) 
 
16 (64) 
0 
9 (36) 
 
40 (52) 
0 
37 (48) 
Number of PROMs reported 
   1 
   2 
   3 
   4 
   5 
 
43 
47 
6 
4 
2 
 
10 
12 
2 
1 
0 
 
33 
35 
4 
3 
2 
 
a IRB= Institutional Review Board. 
b
 Some studies included patients with or without neoadjuvant therapy, some patients undergoing different neoadjuvant or 
adjuvant treatment within the same study. 
 
 
Table 2 Summary of identified patient-reported outcome measures (questionnaires) N=58 
Name of generic questionnaire (n=23) Number of items 
Number of 
scales Overall score 
Frequency 
(n=184) 
Short Form-36 36 8 No 21 
EuroQol-5D 6 6 Yes 3 
Rotterdam Symptom Checklist 35 4 No 3 
Gastrointestinal Quality of Life Index 36 0 Yes 2 
Functional Difficulty Index 15 0 Yes 2 
Illness Impact Scale 9 0 Yes 2 
Visual Analogue Scale (overall health) 1 0 Yes 2 
Self-rated health* - - - 1 
Freiburger Illness Coping Strategies questionnaire* - - - 1 
Brief Symptom Inventory-18 18 3 Yes 1 
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Constructed Meaning Scale 8 0 Yes 1 
Surgical Recovery Score 31 0 Yes 1 
Nottingham Health Profile 45 6 Yes 1 
Duke Generic Instrument 17 11 Yes 1 
Instrumental Activities of Daily Living 7 0 Yes 1 
Profile of Moods States 65 6 Yes 1 
Health and Activities Limitation Index 8 2 Yes 1 
Health Utility Index 7 7 Yes 1 
Spitzer Quality of Life Index 5 5 Yes 1 
Global Quality of Life* - - - 1 
Multidimensional Functional Assessment Questionnaire* - - -  1 
Symptom Experience Scale 24 6 Yes 1 
Ad-hoc satisfaction questionnaire# 6 6 Yes 1 
Name of cancer-specific questionnaire (n=4)     
EORTC QLQ-C30 30 15 No 50 
Cancer-related Health Worries Scale 4 0 Yes 2 
Quality of Life – Cancer Survivors 41 4 No 1 
Cancer Problems in Living Scale 31 0 Yes 1 
Name of disease-specific questionnaire (n=11)     
EORTC QLQ-CR38 38 9 No 33 
Functional Assessment of Cancer Therapy-Colorectal 37 5 Yes 5 
Modified City of Hope Quality of life-Ostomy 41 6 Yes 2 
EORTC QLQ-CR29 34 4 No 1 
University of Padova Bowel Function questionnaire 8 0 Yes 1 
Bowel Function questionnaire 8 0 Yes 1 
Bowel Problems Scale 7 7 No 1 
Late Effects Normal Tissue – Subjective, objective, management, 
analytic scale* 
- - 
- 1 
Quality of Life Index for Colostomy Patients 23 3 No 1 
Colorectal Cancer Quality of Life 62 4 Yes 1 
COloREctal Functional Outcome Questionnaire 26 5 Yes 1 
Name of symptom-specific questionnaire (n=17)     
International Index of Erectile Function 15 5 Yes 4 
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 Abbreviations:  EORTC: European Organisation for Research and Treatment of Cancer *Questionnaire not available # PROM 
not validated 
 
 
 
 
 
 
 
 
 
 
Faecal Incontinence Quality of Life questionnaire 29 4 No 3 
Wexner Incontinence Scale 5 0 Yes 3 
Visual Analogue Scale (pain) 1 0 Yes 3 
Center for Epidemiologic Studies – Depression 20 6 Yes 3 
Hospital Anxiety and Depression Scale 14 0 Yes 2 
Holschneider questionnaire 8 0 Yes 1 
Internation Index of Erectile Function-5 5 5 Yes 1 
Body Image Questionnaire 10 2 No 1 
Body Image Scale 10 0 Yes 1 
Faecal Incontinence Scoring System 5 0 Yes 1 
Patient Assessment of Constipation Symptom Scale 12 3 Yes 1 
Present Pain Intensity Index 1 0 Yes 1 
Satisfaction with Sexual Function 1 0 Yes 1 
Visual Analogue Scale (wound satisfaction) 1 0 Yes 1 
Symptom Distress Scale 15 0 Yes 1 
Multidimensional Fatigue Inventory-20 20 5 No 1 
Name of questionnaire (n=3)     
Ad hoc QOL questionnaire A*# - - - 1 
Ad-hoc QOL questionnaire B*# - - - 1 
Ad-hoc QOL questionnaire C*# - - - 1 
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Table 3   Summary of domain categorization including number of items per domain, numbers 
of PROMs, and median items per PROM 
 
PRO Domain (n=51) Number of items 
n=917 (%) 
Number of 
PROMs n=50 (%) 
Median items per 
source PROM (range) 
Psychological domains 
Anxiety 85 (9.2) 22 (44) 2.5 (1-12) 
Fatigue 67 (7.2) 21 (42) 1.0 (1-23) 
Depression 47 (5.1) 16 (32) 1.5 (1-12) 
Body image 37 (4.0) 13 (26) 1.0 (1-10) 
Frustration/irritability 15 (1.6) 7 (14) 1.0   (1-9) 
Outlook on life 13 (1.4) 5 (10) 2.0   (1-6) 
Self-esteem 11 (1.2) 6 (12) 2.0   (1-3) 
Coping 10 (1.1) 6 (12) 1.0   (1-3) 
Spiritual 7 (0.7) 2 (4) 3.5   (3-4) 
Regret 5 (0.5) 2 (4) 2.5  (1-4) 
Control 3 (0.3) 3 (6) 1.0      (1) 
Functional domains    
Physical function 63 (6.8) 19 (38) 1.0   (1-9) 
Role function 51 (5.5) 20 (40) 2.0   (1-7) 
Social function 50 (5.4) 22 (44) 2.0   (1-8) 
Sexual function 44 (4.7) 13 (26) 1.0 (1-15) 
Cognitive function 30 (3.2) 14 (28) 1.0   (1-7) 
Symptom domains    
Faecal incontinence 53 (5.7) 12 (24) 2.0 (1-27) 
Stoma problems 52 (5.6) 5 (10) 7.0 (7-21) 
Pain 50 (5.4) 18 (36) 1.5   (1-8) 
Insomnia 18 (1.9) 13 (26) 1.0   (1-4) 
Appetite/eating problems 17 (1.8) 10 (20) 1.5   (1-3) 
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Faecal frequency 14 (1.5) 8 (16) 2.0   (1-3) 
Nausea/vomiting 12 (1.3) 8 (16) 1.0   (1-3) 
Faecal Urgency 11 (1.2) 8 (16) 1.0   (1-2) 
Flatulence or Gas 11 (1.2) 7 (14) 1.0   (1-3) 
Treatment problems 11 (1.2) 7 (14) 1.0   (1-3) 
Rectal blood or mucus  10 (1.1) 8 (16) 1.0   (1-2) 
Bloating 7 (0.7) 6 (12) 1.0   (1-2) 
Diarrhoea 7 (0.7) 7 (14) 1.0      (1) 
Tenesmus 7 (0.7) 4 (8) 2.0   (1-2) 
Constipation 6 (0.6) 5 (10) 1.0   (1-2) 
Shortness of breath 5 (0.5) 5 (10) 1.0      (1) 
Urinary Frequency 5 (0.5) 3 (6) 2.0   (1-2) 
Faint or Dizzy 4 (0.4) 4 (8) 1.0      (1) 
Hair Problems 4 (0.4) 4 (8) 1.0      (1) 
Discrimination 3 (0.3) 3 (6) 1.0      (1) 
Dry Mouth 3 (0.3) 3 (6) 1.0      (1) 
Menstruation 3 (0.3) 3 (6) 1.0      (1) 
Taste 3 (0.3) 3 (6) 1.0      (1) 
Duration of bowel movement 2 (0.2) 2 (4) 1.0      (1) 
Dyspepsia 2 (0.2) 2 (4) 1.0      (1) 
Dysphagia 2 (0.2) 1 (2) 2.0      (2) 
Dysuria 1 (0.1) 1 (2) 1.0      (1) 
Urinary Incontinence 1 (0.1) 1 (2) 1.0      (1) 
Global domains    
Global quality of life 12 (1.3) 9 (18) 1.0   (1-2) 
Self-care 10 (1.1) 10 (20) 1.0      (1) 
Financial 8 (0.9) 5 (10) 1.0   (1-4) 
Satisfaction with care 6 (0.6) 1 (2) 6.0      (6) 
Information needs 1 (0.1) 1 (2) 1.0      (1) 
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Table 4: OvidSP version of Medline search strategy 
Search criteria Search terms 
Colorectal cancer 1. exp Colonic Neoplasms/ 
2. exp Rectal Neoplasms/ 
3. ((colorect$ or colon or colonic or rect$) adj3 (cancer$ or tumo?r$ or 
neoplasm$ or carcinoma$ or adenocarcinoma$ or malignan$)).tw. 
4. or/1-3 
Surgery 1. exp Specialties, Surgical/ 
2. surg$.tw. 
3. operat$.tw. 
4. intervention$.tw. 
5. procedur$.tw. 
6. resect$.tw. 
7. or/1-6 
Randomised controlled 
trials/prospective studies 
1. randomized controlled trial.pt. 
2. controlled clinical trial.pt. 
3. randomized controlled trials.sh. 
4. random allocation.sh. 
5. double blind method.sh. 
6. single-blind method.sh. 
7. or/1-6 
8. exp animals/ not human/ 
9. 7 not 8 
10. clinical trial.pt. 
11. exp clinical trials/ 
12. (clin$ adj25 trial$).ti,ab. 
13. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab. 
14. placebos.sh. 
15. placebo$.ti,ab. 
16. random$.ti,ab. 
17. research design.sh. 
18. or/10-17 
19. 18 not 8 
20. 19 not 9 
21. comparative study.sh. 
22. exp evaluation studies/ 
23. follow up studies.sh. 
24. prospective studies.sh. 
25. (control$ or 18prospective$ or volunteer$).ti,ab. 
26. or/21-25 
27. 26 not 8 
28. 27 not (9 or 20) 
29. 9 or 20 or 28 
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Acronyms 
COS – Core outcome set 
CRC – Colorectal cancer 
PRO – Patient-reported outcome 
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Figure 1 
 
PRISMA diagram of studies considered for the systematic review. 
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